The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Travel, Accommodations, Expenses - Celgene; Janssen
Daratumumab plus bortezomib-melphalan-prednisone (VMP) in elderly (≥75 y) patients (Pts) with newly diagnosed multiple myeloma (NDMM) ineligible for transplantation (ALCYONE).
 
Michele Cavo
No Relationships to Disclose
 
Shinsuke Iida
Honoraria - Bristol-Myers Squibb; Celgene; Janssen; Novartis; Ono Pharmaceutical; Takeda
Consulting or Advisory Role - Janssen; Ono Pharmaceutical; Sanofi; Takeda
Research Funding - Abbvie; Bristol-Myers Squibb; Celgene; Chugai Pharma; Gilead Sciences; Janssen; Kyowa Hakko Kirin; MSD; Novartis; Ono Pharmaceutical; Takeda
 
Joan Blade
Honoraria - Amgen; Celgene; Janssen; Takeda
Research Funding - Celgene; Janssen
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen; Takeda
 
Maria-Victoria Mateos
Honoraria - Amgen; Celgene; Janssen-Cilag; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Takeda
 
Je-Jung Lee
No Relationships to Disclose
 
Mamta Garg
Consulting or Advisory Role - Janssen
Travel, Accommodations, Expenses - Takeda
 
Vania Hungria
Honoraria - Amgen; Celgene; Janssen; Roche; Takeda
 
Meral Beksac
Consulting or Advisory Role - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen-Cilag (Inst); Novartis (Inst); Takeda (Inst)
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag
 
Ivan Spicka
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Millennium
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen
Research Funding - Celgene
 
Stefan Knop
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen
Travel, Accommodations, Expenses - Celgene; Novartis
 
Ludek Pour
No Relationships to Disclose
 
Philip Campbell
No Relationships to Disclose
 
Andrzej J. Jakubowiak
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Sanofi; Skyline Diagnostics; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Karyopharm Therapeutics; Skyline Diagnostics; Takeda
 
Jianping Wang
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Susan Wroblewski
Employment - Janssen Research & Development
Stock and Other Ownership Interests - GlaxoSmithKline; Janssen Research & Development; Novartis
Travel, Accommodations, Expenses - Janssen Research & Development
 
Rachel Kobos
Employment - Janssen
 
Ming Qi
Employment - Janssen
 
Jesus San-Miguel
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; MSD; Novartis; Roche; Sanofi; Takeda